Latest News

FDA Plans to Increase Clinical Trial Data Transparency
Clinical trial data that leads to FDA approvals may be difficult for the general public to understand.
Pembrolizumab (Keytruda) combination therapy may improve outcomes for patients with metastatic non-small cell lung cancer.
The presence of certain bacteria may enhance response to PD-1 inhibitors in melanoma.
Once-weekly pill has the potential to prevent 20% of new HIV infections.
Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.
Mitochondrial inhibitors may be a beneficial add-on therapy for glioblastoma containing gene fusion.
Top news of the day from across the health care landscape.
Americans to walk, bike or run 7,000 miles during February bringing awareness to 7,000 rare diseases affecting 30 million Americans.

Features

Specialty Drugs: Year in Review 2017 Part I
Specialty pharmaceuticals featured prominently in the actions of the FDA in 2017.
To date, significant uncertainty surrounds the adoption of digital health tools into clinical development programs and trial protocols.
Partnerships are key between home infusion and hospitals to alleviate costs on the health system.
Through value-based care initiatives, payers are increasingly holding both providers and pharmaceutical manufacturers accountable for choosing the right combination of drug regimens and treatment protocols.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses what drove him to join the world of specialty pharmacy and the most rewarding part of it.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about data analytics and specialty pharmacy.

A look at the top stories in the world of pharmacy from last week.

Current Issue

November/December
Volume: 8
Number: 7

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$